You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 15, October 20, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Report
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Thrombolysis
 •Neurology
 •Cerebrovascular Disease
 •Stroke
 •Cardiovascular System
 •Prognosis/ Outcomes
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Long-term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion

Perttu J. Lindsberg, MD, PhD; Lauri Soinne, MD; Turgut Tatlisumak, MD, PhD; Risto O. Roine, MD, PhD; Mikko Kallela, MD, PhD; Olli Häppölä, MD, PhD; Markku Kaste, MD, PhD, FAHA

JAMA. 2004;292:1862-1866.

Context  Basilar artery occlusion (BAO) is an infrequent disease with high morbidity and mortality. Intra-arterial thrombolysis is advocated for treatment but is limited to use at specialized centers.

Objective  To evaluate outcomes for patients with BAO treated with intravenous thrombolytic therapy.

Design, Setting, and Participants  During 1995 to 2003, 50 consecutive patients with angiographically proven BAO were treated according to an institutional therapy protocol based on intravenous thrombolysis with recombinant tissue plasminogen activator (alteplase). Patients were treated at an urban university teaching hospital receiving all patients with ischemic stroke who were considered for thrombolysis in a catchment area of 1.5 million inhabitants in Helsinki, Finland.

Intervention  Intravenous administration of alteplase (0.9 mg/kg) during a 1-hour infusion.

Main Outcome Measures  Basilar artery recanalization determined by magnetic resonance angiography and clinical outcomes at 3 months and at 1 year or longer determined by modified Rankin Scale and Barthel Index scores.

Results  Recanalization was studied in 43 patients and verified in 26 (52%) of all patients. By 3 months, 20 patients (40%) had died while 11 had good outcomes (modified Rankin Scale score, 0-2); 12 (24%) reached independence in activities of daily living (Barthel Index score, 95-100), and 6 (16%) were severely disabled (Barthel Index score, 0-50). In the long term (median follow-up 2.8 years), 15 patients (30%) reached good outcomes (modified Rankin Scale score, 0-2) while 23 (46%) died.

Conclusions  Intravenous administration of alteplase for patients with BAO appears to be associated with rates of survival, recanalization, and independent functional outcome comparable with those reported with endovascular approaches. These data suggest that a randomized trial is needed to compare these approaches for treatment of BAO.


Author Affiliations: Department of Neurology, Helsinki University Central Hospital (Drs Lindsberg, Soinne, Tatlisumak, Roine, Kallela, Häppölä, and Kaste); and Neuroscience Program, Biomedicum Helsinki (Drs Lindsberg and Tatlisumak), Helsinki, Finland.

Corresponding Author: Perttu J. Lindsberg, MD, PhD, Department of Neurology, Helsinki University Central Hospital, PO Box 340, 00029 HUS, Helsinki, Finland (perttu.lindsberg{at}hus.fi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Treatment of Acute Stroke: Still Struggling
Louis R. Caplan
JAMA. 2004;292(15):1883-1885.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

BRAINSTEM LESIONS IN DIFFUSION SEQUENCES OF MRI CAN BE REVERSIBLE AFTER ARTERIAL RECANALIZATION
Vilas et al.
Neurology 2009;73:813-815.
FULL TEXT  

Thrombolysis in Young Adults With Ischemic Stroke
Putaala et al.
Stroke 2009;40:2085-2091.
ABSTRACT | FULL TEXT  

Brain Stem Diffusion-Weighted Imaging Lesion Score: A Potential Marker of Outcome in Acute Basilar Artery Occlusion
Cho et al.
Am. J. Neuroradiol. 2009;30:194-198.
ABSTRACT | FULL TEXT  

Staged Escalation Therapy in Acute Basilar Artery Occlusion: Intravenous Thrombolysis and On-Demand Consecutive Endovascular Mechanical Thrombectomy: Preliminary Experience in 16 Patients
Pfefferkorn et al.
Stroke 2008;39:1496-1500.
ABSTRACT | FULL TEXT  

Timing of Recanalization After Microbubble-Enhanced Intravenous Thrombolysis in Basilar Artery Occlusion
Pagola et al.
Stroke 2007;38:2931-2934.
ABSTRACT | FULL TEXT  

Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
De Keyser et al.
Stroke 2007;38:2612-2618.
ABSTRACT | FULL TEXT  

Mast Cell Stabilization Reduces Hemorrhage Formation and Mortality After Administration of Thrombolytics in Experimental Ischemic Stroke
Strbian et al.
Circulation 2007;116:411-418.
ABSTRACT | FULL TEXT  

Ischaemic stroke: acute management, intensive care, and future perspectives
Kollmar and Schwab
Br J Anaesth 2007;99:95-101.
ABSTRACT | FULL TEXT  

Therapy of Basilar Artery Occlusion: Individual Protocols Needed
Vatankhah et al.
Stroke 2007;38:e29-e29.
FULL TEXT  

Admission Facility Is Associated With Outcome of Basilar Artery Occlusion
Muller et al.
Stroke 2007;38:1380-1383.
ABSTRACT | FULL TEXT  

Endovascular Recanalization of Basilar Artery Occlusion 80 Days After Symptom Onset
Yu et al.
Stroke 2007;38:1387-1389.
ABSTRACT | FULL TEXT  

Thrombolysis of Basilar Artery Occlusion--Intra-Arterial or Intravenous: Is There Really No Difference?
Schulte-Altedorneburg et al.
Stroke 2007;38:9-9.
FULL TEXT  

Response to Letter by Schulte-Altedorneburg et al
Lindsberg and Mattle
Stroke 2007;38:10-11.
FULL TEXT  

Outcome of Acute Vertebrobasilar Occlusions Treated with Intra-Arterial Fibrinolysis in 180 Patients
Schulte-Altedorneburg et al.
Am. J. Neuroradiol. 2006;27:2042-2047.
ABSTRACT | FULL TEXT  

Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia.
Weimar et al.
Arch Neurol 2006;63:1287-1291.
ABSTRACT | FULL TEXT  

Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Pro
Donnan et al.
Stroke 2006;37:2436-2437.
FULL TEXT  

Response to Letter by Schonewille et al
Lindsberg and Mattle
Stroke 2006;37:2207-2207.
FULL TEXT  

Therapy of Basilar Artery Occlusion: A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis
Lindsberg and Mattle
Stroke 2006;37:922-928.
ABSTRACT | FULL TEXT  

Use of mechanical extraction devices in basilar artery occlusion
Favrole et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1462-1464.
ABSTRACT | FULL TEXT  

Aggressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion: Combined Local Fibrinolysis and Intravenous Abciximab in Acute Vertebrobasilar Stroke Treatment (FAST): Results of a Multicenter Study
Eckert et al.
Stroke 2005;36:1160-1165.
ABSTRACT | FULL TEXT  

Options for Recanalization Therapy in Basilar Artery Occlusion
Lindsberg et al.
Stroke 2005;36:203-204.
FULL TEXT  

Thrombolysis: What More Does It Take?
Kaste
Stroke 2005;36:200-202.
FULL TEXT  

IV Thrombolysis Works for Basilar Artery Occlusion, Too
JWatch Emergency Med. 2005;2005:7-7.
FULL TEXT  

Intravenous Thrombolysis for Basilar Artery Occlusion?
JWatch General 2004;2004:2-2.
FULL TEXT  

Treatment of Acute Stroke: Still Struggling
Caplan
JAMA 2004;292:1883-1885.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.